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Abstract
Background: Tuberculosis is a mycobacterial infection causing worldwide public health problems but the available vaccine
is far from ideal. Type-1 T cell immunity has been shown to be critical for host defence against tuberculosis infection, but
the role of dendritic cell (DC) subsets in pathogenesis of mycobacterial infection remains unclear.
Methodology/Principal Findings: We examined the effectiveness of dendritic cell (DC) subsets in BCG-infected mice in
generating immune responses beneficial for pathogen clearance and reduction of pathological reactions in the tissues
following challenge infection. Our data showed that only the adoptive transfer of the subset of CD8a
+ DC isolated from
infected mice (iCD8
+ DC) generated significant protection, demonstrated by less mycobacterial growth and pathological
changes in the lung and liver tissues in iCD8
+ DC recipients than sham-treated control mice. The adoptive transfer of the
CD8a
2DC from the infected mice (iCD8
2 DC) not only failed to reduce bacterial growth, but enhanced inflammation
characterized by diffuse heavy cellular infiltration. Notably, iCD8
2 DC produced significantly higher levels of IL-10 than iCD8
+
DC and promoted more Th2 cytokine responses in in vitro DC-T cell co-culture and in vivo adoptive transfer experiments.
Conclusions/Significance: The dataindicatethatin vivoBCG-primedCD8
+D Ci sth ed o mi n a n tD Csu b s e ti ni n du c i n gp r o t e c ti v e
immunity especially for reducing pathological reactions in infected tissues. The finding has implications for the rational
improvement of the prophylactic and therapeutic approaches for controlling tuberculosis infection and related diseases.
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Introduction
Tuberculosis is a type of mycobacterial infection that causes
serious public health problems worldwide. The World Health
Organization (WHO) estimates that about 2 billion people, meaning
one third of the world’s population, are infected with Mycobacterium
tuberculosis (Mtb) [1,2]. More importantly, the incidence of
tuberculosis continues to rise due to the spread of HIV infection
and the emergence of multi-drug-resistant Mtb strains [3,4]. Mtb
infection is the leading cause of death in AID patients. BCG (Bacille
Calmette -Gue ´rin) is the only registered human vaccine for
prevention of Mtb infection and diseases. Although its protective
effect has been well established, its efficacy is quite variable and far
from ideal [5]. A better understanding of the mechanism by which
BCG immunization protects host from challenge infection may be
not only useful for the possible improvement of the efficacy of this
particular vaccine but also have implications in the rational
development of new vaccines for tuberculosis.
Although the mechanism remains unclear, the host protection
against Mtb infection has been found to be largely dependent on T
cell mediated immunity especially type-1 T cell responses. The
influence of type-2 T cells and humoral immune responses to host
defence is limited and even detrimental in certain circumstances.
Human studies have shown that Th1 response is essential for the
host protection from mycobacterial infections [6]. The human
subjects deficient in receptors for IFN-c and IL-12 are profoundly
susceptible to mycobacterial infections [7,8]. Experimental studies
using animal models also confirmed the critical importance of Th1
responses in protective immunity and the control of pathological
reactions (reviewed in [8,9].
T cell response is a downstream event in the immune system,
following the capture, process and presentation of antigenic
peptides by antigen-presenting cells (APC). Along with macro-
phages and others, dendritic cells (DCs) are a type of the front line
cells that encounter Mycobacteria in the infection sites. DCs are the
key APCs in the activation of primary CD4 T cells and in the
polarization of Th1/Th2 subsets. It has been shown that Mtb-
infected DCs, but not macrophages, can drive naı ¨ve CD4
+ T cells
polarize to Th1 pathway [10]. The DCs in the lung play a central
role in initiating the immune response to tuberculosis [11]. DCs
can influence the polarization of naive T cell to different types of
effector T cells [12,13]. Since DC is a heterogeneous population,
different DC subtypes may contribute differently on the activation
and polarization of mycobacterial antigen-specific T cells. Indeed,
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in individuals with mycobacterial infection[14]. In human,
CD16
2mDC and CD16
+mDC subsets have been found to be
different in preferential activation of T memory cells, showing that
CD16
+mDC elicits stronger IFNc response than CD16
2mDC[15].
In mice, splenic CD8a
+ and CD8a
2 DC subsets have been
extensively studied and some functional differences between the two
subsets have been reported in several model systems including
infections, although some studies showed overlapping functions of
the two subsets [16–20]. In particular, we have reported that
CD8a
+ DC isolated from Chlamydia muridarum infected mice are
more potent in inducing protection against challenge infection with
the same Chlamydia species than CD8
2 DC[21]. Little is known
about the functional involvement of DC subsets in BCG induced
protective immunity against mycobacterial infection.
In the present study, we examined the relative effectiveness of
splenic CD8a
+(CD8
+) and CD8a
2 (CD8)DC subsets in BCG-
infected mice in generating type-1 T cell responses and protection
against challenge infection with an intention to know more on the
mechanism by which a host defenses against Mtb infection. The
data showed that the distinct DC subsets primed by in vivo BCG
immunization are significantly different in their potency to induce
protective immunity against challenge mycobacterial infection.
Specifically, we found that CD8a
+ DC is much more potent than
CD8a
2 DC for inducing type-1 T cell responses in both in vitro
and in vivo conditions. This difference is unlikely due to the
potential difference of the subsets in uptaking mycobacterial
organisms because quantitative RT-PCR test showed similar levels
of bacterial messages in the isolated DC subsets. Rather, it is more
likely due to the functional difference of the DC subsets in
modulating T cell responses.
Materials and Methods
Mice and Culture Medium
Female C57BL/6 mice were bred at the University of Manitoba
breeding facility and hosted under specific-pathogen-free condi-
tions. Animals were used in accordance with the guidelines issued
by the Canadian Council on Animal Care. The animal experi-
mental protocol was approved by the ethical committee of The
University of Manitoba.
Complete RPMI 1640 medium supplemented with 10% heat–
inactivated fetal bovine serum, 1%L-glutamine, 25 mg/ml genta-
mycin and 5610
25M 2-mercaptoethanol was used for cell culture.
Organism
The original BCG vaccine was produced by Aventid Pasteur
Limited (Toronto, Ontario, Canada). For expansion of the vaccine,
BCG was grownintheMiddlebrook’s7H9 broth(Difco Laboratories
Inc., Detroit, MI) containing 0.2%(v/v) glycerol and 0.05%(v/
v)Tween-80 and supplied with 10%(v/v) Middlebrook ADC
enrichment (Difco) for 21days. The number of BCG bacilli, counted
as colony-forming units (CFU), was measured by plating diluted
culture on plates of Middlebrook 7H11 agar (Difco) containing
0.5%(v/v)glycerol and supplied with Middlebrook OADC enrich-
ment(Difco). The BCG stock was stored at 280uCu n t i lu s e .F o r
inactivation of BCG, live BCG was put at 65uC for 1 hour, which led
to complete killing of BCG confirmed by viability testing.
Mice Immunization
Mice were injected intravenously with 5610
5 CFU BCG in
200 mL sterile protein-free PBS and sacrificed at day 21 after
infection. Spleens were aseptically isolated and treated as following:
Briefly, the spleens were digested in 1.5 mg/ml collagenase D at
37uC for 30 min and EDTA was applied at the last 5 min to disrupt
DC-T complexes. The cell suspensions was then pipetted up and
down several times and filtered.
DC Subset Isolation
For total DC (CD11c
+) isolation, the splenocytes after RBC lyses
with ACK lyses buffer(150 mM NH4Cl, 10 mM KHCO3,
0.1 mM EDTA) were incubated with the MACS (Miltenyi Biotec,
Auburn, CA) CD11c beads for 15 min at 4uC. The cells were
washed and passed through the LS columns for selection of
CD11c
+ cells. For isolation of DC subset (CD11c
+CD8
+DC and
D11c
+CD8
2DC), MACS CD8
+DC positive selection kit was used
according to the manufacturer’s instructions. Briefly, spleen cells
were incubated with cocktail of biotin-conjugated antibodies
against antibodies (CD90, CD45R, CD49b), followed by incuba-
tion with anti-biotin microbeads to deplete of T, B and NK cells.
The CD8
+DC subset was isolated from the T,B and NK cell
depleted preparation by incubating it with CD8
+ cell selecting
beads for 30 min on ice and passing through LD columns. The
CD8
2DC subset was further isolated from this preparation using
CD11c column. The purity of the total DC and DC subset was
.95% based on flow cytometry analyses.
Flow Cytometric Analysis
For analysing total DC, purified CD11c
+ DCs (2610
6 the cells)
were pre-incubated with anti-mouse CD16/32 mAb for 15 min to
block FcR binding before staining with specific antibodies. Cells
were then incubated with specific mAbs at 4uC for 30 min in dark.
After washing with a staining buffer [Dulbecco’s PBS (Sigma-
Aldrich) without Ca
2+ and Mg
2+ containing 2% heat-inactivated
FCS and 0.05% NaN3], the cells were fixed and analysed using
FACS Calibur flow cytometer (BD Biosciences) and the data were
analyzed using Cell Quest
TM software (Becton Dickinson). To
analyzed surface marker expression on DC subsets, three color-
staining was performed. CD11c-allophycocyanin (Hamster IgG)
and anti CD8-PE-Cy7 (Rat IgG2a k) were used for gating DC
subsets and FITC conjugated anti-CD80 (Hamster IgG), CD86
(Rat IgG2b k), CD40 (Rat IgG2a k) and MHC-II (Rat IgG2b)
were used for the specific markers. The florescence-conjugated
appropriate isotype controls antibodies were used as control.
Intracellular cytokines were analyzed as we previously de-
scribed[22]. Briefly, freshly isolated draining lymph node cells
(2610
6 cells) were stimulated with 50 ng/ml phorbol 12-myristate
13-acetate (PMA, Sigma Chemical Co., USA) and 1 mg/ml
ionomycin (Sigma) for 6 hours. 20 mg/ml brefeldin A (Sigma) was
added in the last 3 hours in order to accumulate cytokines
intracellularly. After washing with a staining buffer, cells were
incubated with anti-mouse CD16/32 (Fc block, e-Bioscience) for
30 min on ice to block the FcR non-specific binding and
subsequently stained for surface markers with PE-anti-CD4,
FITC-anti-CD3e, PerCy-anti-CD8 or isotype controls for
30 min on ice. The cells were fixed and permeabilized with
Cytofix/Cytoperm
TM buffer (BD BioScience) for 20 minutes at
4uC and incubated with allophycocyanin anti-IFN-c or corre-
sponding isotype controls (eBioscience) for 20 minutes on ice. The
raw sample data were collected using a FACS Calibur flow
cytometer (BD Biosciences) and the data were analyzed using
FlowJo (BD Biosciences).
Adoptive Transfer of DC Subsets and Challenge Infection
Two models were used. For model 1, intravenous route was
used. Purified CD8
+ DCs and CD8
2 DCs from BCG infected
mice were injected intravenously (i.v.) to syngeneic recipient mice
at the amount of 5610
5 cells in 200 ml sterile protein-free PBS.
DC Subsets in BCG Infection
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from naive mice were used as control groups. At day 7 after
adoptive transfer, the mice were challenged with 5610
5 CFU
BCG i.v. and were sacrificed at day 21 after challenge. The lungs
and livers were homogenized in 10 ml PBS and plated in serial
dilutions onto the Middlebrook 7H11 agar with Middlebrook
ADC enrichment. The culture was allowed to proceed for 21 days
at 37uC in an atmosphere of 9% CO2 and the number of CFUs
was counted. For model 2, the DC subsets were adoptively
transferred to recipient mice by intranasal (i.n.) route at the
amount of 2610
5 cells in 40 ml sterile protein-free PBS. Two hours
later, the recipient mice were challenged with 2610
5 CFU BCG
i.n. and killed at day 21 after challenge infection. The BCG CFU
in the lung homogenates were measured as above.
Histopathological Analysis
Lung and liver tissues of the mice with challenge infection were
routinely fixed in 10% buffered formalin, embedded in paraffin,
sectioned by a microtome, stained by hematoxylin and eosin
(H&E) and examined under a light microscope. Infiltrating
inflammatory cells were identified based on cellular morphology
and characteristics.
Cytokine Response Analysis
For analysing cytokine production by cultured spleen cells,
single spleen cells (7.5610
6 cells) were cultured in 1 ml complete
medium for 72 h in the presence of heat-killed (HK)-BCG
(7.5610
5 CFU). Cytokines in the supernatants were measured
using ELISA. For testing cytokine levels in local tissues, the lung
and liver tissues were homogenized in the 10 ml cold PBS. The
supernatant were collected after centrifugation and the cytokine
were measured by the ELISA.
To test the spontaneous cytokines production by the freshly
isolated DC subsets, the DC subsets cells were cultured with
complete medium using 96-well culture plates at 5610
5 cells/well
for 72 hours. The level of IL-12p70 and IL-10 in the culture
supernatants were measured by ELISA.
DC Subsets–T Cell Co-Culture
To directly assess the T cell modulating abilities of DC subsets,
purified DC subsets were cultured with CD4 T cells isolated from
BCG-infected mice as we previously described[22]. CD4 T cells
were isolated from the spleen using the CD4 T cell isolation
column from MACS. The purity of CD4 T cells were .95%. DC
subsets (1610
5 cells/well) and CD4 T cells (1610
6 cells/well) were
co-cultured in 96-well plates in the presence of HK-BCG
(5610
4 CFU/well) in 200 mL complete RPMI medium for
72 hours and the concentration of IFN-c and IL-4 in the
supernatants were measured by ELISA.
Quantitation of BCG Gene Expression in DCs by
Real-Time RT-PCR
To analyze the BCG gene expression in the isolated DC subsets
from BCG infected mice, real-time RT-PCR were performed.
cDNA synthesis is performed using total mRNA primed with
random primer. The thermal profile for RT was incubated at
25uC for 5 min, 50uC for 1 hour. Inactivation of the reaction was
done by heating at 70uC for 15 min. The real-time RT-PCR was
carried out on the MiniOpticon
TM System using an iG
TM SYBR
Green Supermix (BioRad Laboratories, Hercules, California,
USA).The PCR was performed in a 48-well plate in a reaction
volume of 25 ml containing 12.5 ml2 xi G
TM SYBR Green
Supermix Mix, 200 nM each of forward and reverse primer,
0.5 ml template cDNA, added nuclease-free water to a final
volume of 25 ml. The thermal profile for PCR was 95uC for
10 min, followed by 40 cycles of 95uC for 30 s and 58uC for 30 s,
and 72uC for 60 s. Fluorescent signals were read and the data were
collected at each annealing temperature. For each sample, the
amplification plot and the corresponding dissociation curve were
examined. The melting curve analysis, determining the specificity
of the reaction, was carried out immediately after the final PCR
cycle by measuring the changes in fluorescence during slowly
heating the amplicon/probe heteroduplex. The threshold cycle
(Ct) used in the real-time PCR quantification was defined as the
PCR cycle number that a noticeable increase in reporter
fluorescence above a baseline signal. The efficiency of target gene
and GAPDH is similar and a comparative Ct method was used for
calculations[23]. GAPDH was used as an endogenous control
gene for normalization of the amount of RNA added to the
reactions. DCt=Ct(BCG) - Ct(GAPDH), which means the
difference between the threshold cycle of BCG and the threshold
cycle of the corresponding GAPDH in the same sample. For each
experiment, a negative control of nuclease-free water and a
positive control (with known Ct value) were run in triplicate. The
specific primers used in quantitative real-time PCR were: BCG
IS6110 (123 bp): 59CCTGCGAGCGTAGGCGTCGG; 39CTC-
GTCCAGCGCCGCTTCGG. GAPDH (191 bp): 59AACGAC-
CCCTTCATTGAC, 39CACGACTCATACAGCACCT.
Statistical Analysis
One-way ANOVA (One-way analysis of variance) and further
Newman-Keulse test were used to determined statistic significance
among groups. CFU of BCG was converted to logarithmic values
and analyzed using the ANOVA test. The value of P,0.05 was
considered significant.
Results
BCG Immunization Induces Preferential Expansion of
CD8
+ DC Subset Which Exhibits Differential Expression of
Surface Markers and the Production of Cytokines
Compared to CD8
2 DC Subset
To analyze the effect of BCG immunization on DC subset, we
measured CD8 molecule expression on the total DC (CD11c
+
cells) isolated from the spleens of BCG infected and naive C57BL/
6 mice. As shown in Figure 1A, DCs isolated from BCG infected
mice showed a higher percentage of CD8
+ subpopulation than the
DCs from naı ¨ve mice (37% vs 21%), suggesting a preferential
expansion of CD8
+ DC following BCG immunization. Since the
function of DC in modulating immune responses is largely
dependent on their expression of co-stimulatory molecules and the
production of cytokines, we further analyzed the surface markers
on the DC subsets by three-color staining (CD11c, CD8 and a
particular surface marker). As shown in Figure 1B, in comparison
with the CD8
2 DC isolated from BCG infected mice iCD8
2 DC,
the CD8
+ DC isolated from the mice with the same infection
iCD8
+ DC expressed higher CD80 (65.66% vs 17.43%), CD86
(57.43% vs 30%) and CD40 (44% vs 35%) molecules. Similar
differences were observed in comparison of the density (mean
fluorescence intensity, MFI) of these molecules expressed on the
surface of these cells. Although the iCD8
+ DC and iCD8
2 DC
subsets showed similar MHC-II in percentage (97% vs 95%), the
MFI of MHC-II was much higher in iCD8
+ DC. Similar pattern
of differences in expression levels of surface markers were found in
naı ¨ve DC subsets, but the absolute levels in the naı ¨ve mice were
lower than those of infected mice, suggesting a significant impact
of immunization on both DC subsets.
DC Subsets in BCG Infection
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purified iCD8
+ DC and iCD8
2 DC using MACS columns. As
shown in Figure 2A, the sorted DC subsets were in high purity. To
assay the cytokines production pattern of the DC subsets, the
purified iCD8
+ DC and iCD8
2 DC were cultured and the cytokine
levels in the 72 h culture supernatants were measured by ELISA. As
shown in Figure 2B, iCD8
+ DC produced significantly higher level
of IL-12p70 than iCD8
2 DC, which produced more IL-10. Taken
together, the results indicate that BCG immunization leads to a
preferential expansion of CD8
+ DC which shows a different profile
of co-stimulatory surface molecules and cytokines from CD8
- DC.
iCD8
+DC Are More Efficient in Promoting Th1 (IFNc)
Cytokine Production While iCD8
2 DC Are More Efficient
in Promoting Th2 Cytokine (IL-4) Production by T Cells
Primed with BCG In Vivo
Since the analyses shown above on co-stimulatory molecule
expression and cytokines production suggest a functional differ-
ence of the DC subsets isolated from BCG immunized mice, We
performed experiments to address this by co-culturing iCD8
+ DC
and iCD8
2 DC subsets separately with CD4 T cells isolated from
BCG primed mice. As shown in Fig. 3, iCD8
+ DC promoted
dominant Th1-cytokine (IFNc) production, while the iCD8
2DC
induced a dominant Th2 (IL-4) cytokine response by antigen-
specific CD4 T cells. The experiments using an in vitro approach
demonstrated that the DC subsets were functionally different in
directing BCG antigen-specific T cells.
Adoptive Transfer of CD8
+ DC, but Not CD8
2 DC,
Enhanced Bacterial Clearance and Reduced Pathological
Reactions in the Infected Tissues Following Challenge
Infection
To further examine the functional difference of the DC subsets,
we adoptively transferred the iCD8
+ DC and iCD8
2 DC subsets
and tested protection in the recipients of the different DC subsets to
challenge infection. DC subsets were purified from BCG-infected
Figure 1. BCG immunization induced the expansion of CD8
+DC which expressed higher levels of co-stimulatory molecules compared with
CD8
- DC. Mice (C57BL/6, n=4/group) were infected i.v. with 5610
5 CFU of BCG and sacrificed at 21 days after immunization. Total DCs from infected and
naı ¨ve mice were purified using the MACS CD11c
+ isolation column. Purified DCs were co-stained with APC-conjugated anti-CD11c, PE-Cy7-conjugated anti-
CD8 and FITC-conjugated Ab specific for one of the surface markers (CD80, CD86, CD40 or MHCII). The surface marker expression (solid lines) or matched Ab
isotype control (shaded histogram) are shown respectively. All histogram were based on 10,000 cells satisfying a gate set of forward vs side scatter light
histogram. A, purified DCs were gated on CD11c positive cells showing CD8
+ DC population in infected (iDC) and naı ¨ve (nDC) mice. B, purified DC were gated
on either CD11c
+ CD8
+ DC (CD8
+DC) or CD11c
+CD8
2 DC (CD8
2 DC) and the surface molecules on the DC subsets were shown. The percentages of positive
cells and mean fluorescence intensity (MFI) for the molecules were shown at the top and bottom lines respectively at the right upper corner of each histogram.
doi:10.1371/journal.pone.0009281.g001
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i.v. to naı ¨ve C57BL/6 mice. At 7 days after cell transfer, the
recipient mice were challenged i.v. with BCG. Mice that received
PBS (sham treatment) or DC subsets from naive mice with the same
challenge infection were used as controls. Twenty-one days after
challenge infection, mice were sacrificed and the bacterial loads in
the lung and liver were measured. As shown in Fig. 4, a significant
reductionintissue bacterial loads wereobserved in the mouse group
receiving iCD8
+ DC compared with the mice without DC transfer
(sham treated control mice). In contrast, although the recipients of
iCD8
2 DC also appeared to have a trend of lower CFU in the lung
and liver compared to PBS controls, the differences were not
statistically significant. As controls, the recipients of either DC
subsets from naı ¨ve mice (nCD8
+ DC or nCD8
2 DC) showed
comparable levels of bacterial loads with the PBS treated control
mice, therefore not generating protection.
More remarkably, further histopathological analysis (Figure 5)
showed that the recipient of iCD8
+ DC only had mild pathological
changes in the lung and liver. In contrast, the sham-treated mice
and the recipients of iCD8
2 DC showed much more severe
pathological inflammatory reactions. Interestingly, although both
sham-treated mice and iCD8
2 DC recipients showed severe
pathological reactions, their pattern of changes were different.
Sham-treated mice showed multiple granulomas in both lung and
liver tissues, characterized by dominant epithelioid cells (indicated
by green arrows in Fig. 5) at centre with surrounding lymphocytes,
neutrophil and monocytes in peribronchial and perivascular areas
(lung) and peri-central vein areas of the hepatic lobules (liver).
Figure 2. Different levels of cytokine production by DC subsets. DC subsets were isolated from spleens of BCG infected (i.v.) mice at day 21
post-immunization as described in the Materials and Methods. A, purified DC subsets were analyzed by flow cytometry for purity. The 5610
5 sorted
cells were co-stained with APC-conjugated anti-CD11c and PE-conjugated anti-CD8. The purities of the sorted iCD8
+ DC (left) and iCD8
2DC (right) are
indicated at the right upper corner and right lower corner respectively. B, freshly isolated iCD8
+ DC and iCD8
2 DC subsets were cultured. The culture
supernatants were harvested at 72 h and tested for IL-10 and IL-12p70 by ELISA. Data are shown as mean6SD of each group. One representative
experiment of three independent experiments with similar results is shown.*p,0.05, **p,0.01.
doi:10.1371/journal.pone.0009281.g002
Figure 3. iCD8
+ DC and iCD8
2 DC subsets generate different patterns of BCG-driven T cell cytokine production. BCG-specific CD4
+ T
cells (5610
5) cell from BCG-infected mice were co-cultured with iCD8
+ DC or iCD8
2 DC (5610
4 cells/well) in the presence of HK-BCG. Culture
supernatants were collected at 72 h. IFN-c and IL-4 were measured by ELISA. The experiment was repeated twice showing similar results. *p,0.05.
doi:10.1371/journal.pone.0009281.g003
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mice. In contrast, the inflammation in iCD8
2 DC recipients was
diffused without notable granulomas and lack of typical epitheloid
cells. The infiltrating cells in these mice were mainly neutrophils
and mononuclear cell.
Since tuberculosis is mainly a pulmonary disease, we further
analysed the protective function of the DC subsets using a model
of intranasal challenge infection. DC subsets were adoptive
transferred to recipient mice followed by i.n. challenge infection
with live BCG. Similar to what observed in the i.v. infection
model, the recipients of iCD8
+ DC showed lest organism growth
(Figure 4B) and mildest pathological changes (not shown) in the
lung among the groups, exhibiting very few inflammatory cells
following intranasal challenge. In contrast, evident pathological
changes were found in the sham treated control group (multiple
granuloma and heavy inflammation) and iCD8
2 DC recipients
(disseminated heavy inflammation). Taken together, the results
indicate that only the CD8
+ DC subset from infected mice can
generate significant protective immunity in vivo. Moreover, since
granuloma formation is a way for host to control infection
(although not very efficient), the failure of iCD8
2 DC recipients to
have granuloma formation instead showing heavily diffused
inflammation suggest it may promote an inflammatory reaction
which is not protective.
Since proinflammatory cytokine and chemokine responses
contribute to the inflammation of local tissues and correlate with
the degree of pathological reactions in some circumstances, we
further measured the MIP-1a (CCL3), IL-6 and TNF-a
concentration in the lungs and liver. In consistence with the
lowest degree of inflammation in the iCD8
+DC recipients
(Figure 5), this group of mice showed the lowest levels of IL-6,
MIP-1a and TNF-a response in the local tissues (Figure 6). In
contrast, the recipient of iCD8
2DC showed highest levels of these
cytokines, even higher than the sham-treated, infected mice.
Potentially, in the infected tissues many different types of
inflammatory cells can produce these cytokines/chemokine
including, but not limited to macrophages, DCs, and lymphocytes.
The higher levels of these molecules in the lung of the iCD8
2DC
recipients suggest a non-protective or less protective severe
inflammation in the lung, which is not efficient for clearing the
infection but contributes to pathological changes. This data are
consistent with the severe and diffused inflammation in the
iCD8
2DC recipients (Figure 5). The data suggest that the transfer
of iCD8
+DC, but not iCD8
2DC, can reduce the pathological
inflammatory responses in the local tissues.
The Adoptive Transfer of iCD8
+ DC, but Not iCD8
2 DC,
Enhances Type 1 Immune Responses Following
Challenge Infection
Since the type of immune responses plays a critical role in
protection against mycobacterial infection, we further examined
the T cell cytokine patterns and antibody responses in the
recipients of different DC subsets in order to elucidate the
mechanism underlying the difference in protection. As shown in
Figure 7A, significant difference in the production of BCG driven
type-1 related cytokines (IFN-c and IL-12) by bulk cultured spleen
cells was observed between the different groups following
challenge infection. Specifically, the recipient of iCD8
+ DC
showed significantly higher IFN-c production than the control
mice without cell transfer. Analysis of cytokine patterns in the local
Figure 4. Adoptive transfer of iCD8
+DC, but not iCD8
2 DC, reduced bacterial growths in recipients following either i.v. or i.n.
challenge infection. DC subsets were sorted from BCG-infected (i.v.) mice or naı ¨ve mice and adoptively transferred to syngeneic recipients (C57BL/6,
n=4/group) by i.v. (A&B, 5610
5 DC/mouse) or i.n. routes (C, 2610
5 DC/mouse). Mice were challenged with BCG through i.v. (A&B) or i.n. (C) routes,
respectively, as described in Materials and Methods. All mice were sacrificed at day 21 post challenge infection. Homogenized lung or liver tissues were
measured for BCG CFU. The CFUs of BCG were converted to logarithmic values and presented as mean6SD of each group. One representative
experiment of three independent experiments is shown. * p,0.05;**, p,0.01.
doi:10.1371/journal.pone.0009281.g004
DC Subsets in BCG Infection
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(Figure 7B) and liver (Figure 7C) of the iCD8
+ recipient mice
compared to sham control groups and iCD8
2 DC recipient mice.
Serum antibody analysis showed low titers of BCG specific IgG2a
and IgG1 antibodies in all the groups and no significant difference
was observed among the groups (data not shown).
To further examine the local T cell responses, we performed
intracellular cytokine staining of T cells from the draining lymph
nodes following intranasal challenge infection. As shown in
Figure 8, the adoptive transfer of iCD8
+ DC induced more IFN-
c producing T cells than iCD8
2 DC. In particular, recipients of
iCD8
+ DC mounted more than two fold higher IFN-c producing
CD8 T cells than the sham-treated mice. Similarly, more IFNc–
producing CD4 T cells were also found in the recipients of iCD8
+
DC. In contrast, adoptive transfer of iCD8
2 DC failed to enhance
IFNc response by either CD4 or CD8 T cell. Taken together, the
results suggest that iCD8
+ DC has strong ability to promote type-1
T cell responses to mycobacterial challenge infection, which may
be the basis for its strong capacity to generate protection against
both systemic and local challenge infections.
DC Subsets Isolated from BCG Infected Mice Show
Similar Levels of BCG Messages
A question which needed to be addressed was if the differences
observed above for the DC subsets isolated from infected mice in
generating protective immunity was due to the potential difference
of the subsets in BCG loads, thus the amount of antigens carried.
To answer this question, we further analyzed the bacterial loads of
the CD8
+DC and CD8
2DC subsets from BCG infected mice
using quantitative RT-PCR. As shown in Figure 9, the BCG
mRNA levels in the two DC subsets demonstrated in real-time
PCR analysis were comparable. The in vitro culture of either DC
subsets showed negative results for viable BCG. The data suggest
that the DC subsets are not significantly different in carrying BCG
and possibly its antigens.
Discussion
This report assessed the capacity of DC subsets in BCG infected
mice in generating protective immunity against mycobacterial
challenge infection. The data revealed that CD8
+ DCs, but not
CD8
2DCs, from the infected mice are able to induce protection
and reduce pathological reactions in the local tissues of the
recipient mice. This conclusion is supported by the facts that the
recipients of iCD8
+ DCs exhibited significantly less bacterial
growth, much milder histopathological changes and significantly
stronger type-1 immune responses compared to the mice without
cell transfer or received iCD8
2DCs. To our knowledge, this is the
first report showing the different capacity of DC subsets primed by
in vivo immunization by BCG in reducing bacterial loads and
pathological reactions following systemic and local mycobacterial
challenge infection.
Several published studies have used DCs which are infected by
BCG in vitro or are loaded with mycobacterial antigens to
investigate the role of DC in inducing T cell immune responses
and protection using cell adoptive transfer approaches [24,25].
Demangel et al found that bone marrow-derived DCs that were
infected with BCG showed increased expression/production of
MHC class II antigens, co-stimulatory molecules and immune
regulatory cytokines. Intratracheally adoptive transfer of these
Figure 5. Significantly milder pathological changes in recipients of iCD8
+DC following intravenous challenge infection. Mice were
treated/challenged as described in the legend to Figure 4 and analyzed for histopathological changes in lung and liver at day 21 post challenge
infection by H&E staining. Low magnification(x20) and high magnification (x100) were shown respectively. Green arrows indicate typical epithelioid
cells.
doi:10.1371/journal.pone.0009281.g005
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challenge, similar to those induced by in vivo BCG immunization
[24]. Gonzalez-Juarrero et al reported that lung DCs pulsed with
Ag85 (LDC-Ag85) in vitro were able to prime naive CD4
+ T cells
in vivo after adoptively transfer [25]. However, the LDC-Ag85
recipients were not more resistant to Mtb challenge than those
receiving DCs pulsed with an irrelevant protein, instead, showing
more serious consolidation in the lung. Comparing to these
reported studies, our study using DCs primed/infected with BCG
in vivo addressed the function of DCs in a more physiological and
relevant way. Most importantly, our data not only showed the
critical role of DCs in BCG-induced protection against mycobac-
terial challenge infection, but the different capacity of DC subsets
in this matter.
In theory, a potential possibility for the difference of the DC
subsets in generating protective immunity is because the DC
subsets are different in uptaking and/or hosting BCG thus leading
to differential immune responses. This concern is reasonable
because some early studies have shown a poor phagocytic capacity
of CD8
+DC in certain infections [26,27]. However, our analysis
on BCG gene expression in the two DC subsets showed similar
levels of BCG mRNA in the isolated DC subsets (Figure 9). This is
consistent with a reported study showing the similar efficiency of
CD8
+ DC and CD8
- DC in acquiring mycobacteria-derived
antigens [28]. This is also consistent with other reports which
demonstrate a similar efficacy of the CD8
+ DC and CD8
2 DC
subsets in phagocytosis [29,30]. Therefore, the difference in
immune responses generated by the adoptive transfer of the DC
subsets observed in our study is more likely reflecting a functional
difference of the subsets in activating/modulating T cell responses
rather than their difference in handling the microbes/antigens,
especially considering the dramatic difference of the DC subsets in
the expression of co-stimulatory molecules and the production of
immunoregulatory cytokines.
The expression of co-stimulatory cell surface molecules and the
production of cytokines have been shown to be the most important
bases by which DCs modulate the function/polarization of T cell
responses. Our data showing the significant differences of the DC
subsets in the expression and production of these molecules and
cytokines fit well with the functional difference of the DC subsets
in inducing the different types of immune response and protection.
In our study, a higher proportion of iCD8
+ DC expressed
costimulatory surface markers CD80 (65.66% vs. 17.43%), CD86
(57.43% vs. 30%) and CD40 (44% vs. 35%) compared with
Figure 6. Pro-inflammatory cytokine/chemokine levels in local tissues in mice treated with different DC subsets following challenge
infection. The mice were treated as described in the legend to Fig. 4 and the levels of IL-6, MIP-1a and TNF-a proteins in the homogenates of lung
and liver tissues were measure by ELISA.
doi:10.1371/journal.pone.0009281.g006
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2 DC. So were the densities (MFI) of the expressed
molecules. More importantly, iCD8
+ DC predominantly produced
Th1 promoting cytokine, IL-12p70 and IL-12p40 (not shown)
while iCD8
2 DC produced higher IL-10. This is inline with a
reported study showing CD8
2 DCs induced a Th2-type immune
response, while the CD8
+ DCs led to the Th1 differentiation [31].
IL-12 producing DC has been found to be powerful in generating
protection against tuberculosis infection [32,33]. IFN-c is closely
related to protective immunity to tuberculosis infection and is the
principal macrophage-activating cytokine[34], which can stimu-
late the synthesis of reactive oxygen intermediates and nitric oxide
by inducing production of phagocyte oxidase and nitric oxide
synthase within lysosomes. IFN-c induced production of reactive
nitrogen intermediates is one of the most important mechanisms
for controlling mycobacterial infections [35]. Therefore, the higher
production of IL-12 by iCD8
+DC and the subsequently enhanced
IFN-c production induced by the adoptive transfer of this DC
subset is likely the major reason for the better protection of the
iCD8
+DC recipients observed in the present study. In addition to
modulate CD4 T cell response, we also found a significantly higher
IFN-c production by CD8 T cell in the recipients of iCD8
+DC. In
fact, the difference in CD8 T cells for IFN-c production by the
different experimental groups was even more apparent than in
CD4 T cells. This finding is inline with recent reports showing an
exceptional ability of CD8
+DC to present exogenous antigens
through a process of cross-presentation [36,37] and suggests the
importance for enhancing CD8+ T cell responses in promoting
host defense against mycobacterial infections.
A notable characteristic of iCD8
2 DC observed in the present
study is its dramatically higher production of IL-10 compared to
that of iCD8
+ DC. It has been reported that, although IL-10
knockout mice showed little difference in resistance to Mtb
infection than wild-type mice[38], gene transgenic mice that
overly expressed IL-10 exhibited increased reactivation of chronic
Figure 7. Effects of different DC subsets adoptive transfer on Th1-related cytokine production by recipient mice following
challenge infection. A: The recipient mice (C57BL/6, n=4/group) of i.v. adoptive transferred iCD8
+ DC or iCD8
- DC subsets and PBS treated control
mice were challenged i.v. with BCG and sacrificed at day 21 post challenge as described in Materials and Methods. A, splenocytes were cultured at the
concentration of 7.5610
6 cells/well using HK-BCG as stimulator. Culture supernatants were harvested at 72 h and the cytokines were measured by
ELISA. B&C, lungs and livers were homogenized in 10 ml cold protein-free D-PBS and centrifuged. The cytokines levels in the lung (B) and liver (C)
were measured by ELISA. Data are presented as mean6SD of each group. One representative experiment of three independent experiments is
shown. *p,0.05; **, p,0.01.
doi:10.1371/journal.pone.0009281.g007
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2 DC
had nosignificanteffectonBCGloadsinthe lungandliverfollowing
challenge infection. However, histological analysis showed that the
inflammation in the lung and liver tissues of iCD8
2 DC recipients
was not only much heavier than the iCD8
+ DC recipients but also
more severe than the mice without previous DC transfer. Typical
multinucleate giant cells were found around the granulomas in mice
without DC transfer. However, the iCD8
2 DC recipients showed
more diffused inflammation. Granuloma formation is an important
way for the host to control mycobacterial infection, although its
efficiency is not absolute. The most successful control of infection
would lead to resolution of inflammation without granuloma
formation. However, the lack of granuloma formation with diffused
inflammation observed in the iCD8
2 DC recipients implies a lack of
efficientcontrolfortheinfectionandthedevelopmentofmoresevere
pathological inflammation. The highest level of inflammatory
cytokines/chemokine (IL-6, MIP-1a,T N F - a) in the iCD8
2 DC
recipients confirms the severe inflammation in these mice. Since
granuloma in mycobacterial infection is a type-1 granuloma that is
promoted by IFNc and inhibited by IL-10, the higher IL-10
production by iCD8
2 DC may be the basis for the significantly
reduced granuloma formation in its recipients.
It should be noted, however, that the challenge infection used in
the study is BCG instead of virulent Mtb strains which are the real
Figure 8. Intranasal adoptive transfer of iCD8
+DC, but not iCD8
2DC, enhanced IFN- c production by T cell. Mice were adoptively
transferred i.n. with iCD8
+DC or iCD8
2DC subsets followed by the challenge with BCG through i.n route as described in Materials and Methods.
Draining lymph nodes was isolated aseptically and single cell suspension was prepared in cold staining buffer. Cells were co-stained with FITC-anti
CD3e, PE-anti CD4, PerCP-anti CD8 Abs and stained for intracellular IFN-c using allophycocyanin -conjugated anti-IFNc Ab as described in Materials
and Methods. Cells were gated on CD3e
+T cells, CD3e
+CD4
+T cell and CD3e
+CD8
+T cell respectively and the percentage of positive cells for IFN-c is
indicated in upper right corner (A). Pooled data in each group are shown as mean6SD (B). One representative experiment of two independent
experiments is shown. *p,0.05; **, p,0.01.
doi:10.1371/journal.pone.0009281.g008
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by virulent Mtb requires additional parameters. Therefore
cautions are needed in interpreting the data from this study.
Further study using virulent Mtb as challenge infection would be
important. On the other hand, since many similarities in immune
responses to BCG and Mtb have been reported and BCG has been
used for modeling host defense against Mtb in many studies, the
data from current study are very useful for guiding future studies
and for understanding host defense mechanisms against Mtb
infection.
In conclusion, the present study has demonstrated that different
DC subsets from BCG-infected mice are different in capacity to
generate protective immunity. The functional difference may be
related to their expression of co-stimulatory molecules and
cytokine production patterns. The data suggest that proper
targeting and/or modulating ‘‘right’’ DC subset may have the
potential to improve the efficiency of vaccination to generate
protective immunity. This knowledge may have implications in the
development and improvement of the approaches for prevention
and therapy of tuberculosis infection and subsequent sequelae.
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